U.S. Markets open in 8 hrs 40 mins
  • S&P Futures

    3,300.25
    +1.00 (+0.03%)
     
  • Dow Futures

    27,253.00
    +110.00 (+0.41%)
     
  • Nasdaq Futures

    11,113.50
    -36.00 (-0.32%)
     
  • Russell 2000 Futures

    1,489.30
    +0.50 (+0.03%)
     
  • Crude Oil

    39.55
    -0.05 (-0.13%)
     
  • Gold

    1,893.20
    -14.40 (-0.75%)
     
  • Silver

    23.75
    -0.77 (-3.15%)
     
  • EUR/USD

    1.1684
    -0.0026 (-0.2220%)
     
  • 10-Yr Bond

    0.6640
    0.0000 (0.00%)
     
  • Vix

    26.86
    -0.92 (-3.31%)
     
  • GBP/USD

    1.2722
    -0.0014 (-0.1107%)
     
  • BTC-USD

    10,493.42
    -48.33 (-0.46%)
     
  • CMC Crypto 200

    222.42
    +8.66 (+4.05%)
     
  • FTSE 100

    5,829.46
    +25.17 (+0.43%)
     
  • Nikkei 225

    23,266.06
    -94.24 (-0.40%)
     

MERGER ALERT - NTN, PRNB, and CBMG: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESSWIRE / August 24, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.

NTN Buzztime, Inc. (NYSE:NTN)
Agreement Announcement: August 13, 2020
Transaction Details: Under the terms of the merger, immediately following the closing, the members of Brooklyn collectively will own 94.08% of the outstanding common stock of the combined company and Buzztime stockholders will own 5.92% of the outstanding common stock of the combined company.

To learn more about the NTN investigation and your rights, go to:
https://www.zlk.com/mna2/ntn-buzztime-inc-information-request-form

Principia Biopharma Inc. (NASDAQ:PRNB)
Agreement Announcement: August 17, 2020
Transaction Details: Under the terms of the merger, Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash.

To learn more about the PRNB investigation and your rights, go to:
https://www.zlk.com/mna2/principia-biopharma-inc-information-request-form


Cellular Biomedicine Group, Inc. (NASDAQ:CBMG)
Agreement Announcement: August 12, 2020
Transaction Details: Under the terms of the merger, Cellular Biomedicine stockholders will receive $19.75 in cash for each outstanding share of common stock held immediately prior to the effective time of the merger.

To learn more about the CBMG investigation and your rights, go to:
https://www.zlk.com/mna2/cellular-biomedicine-group-inc-information-request-form

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@levikorsinsky.com
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP



View source version on accesswire.com:
https://www.accesswire.com/603150/MERGER-ALERT--NTN-PRNB-and-CBMG-Levi-Korsinsky-LLP-Reminds-Investors-of-Investigations-Concerning-the-Mergers-of-these-Companies